Elizabeth Masson's most recent trade in CorMedix Inc was a trade of 100,000 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on Feb. 18, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CorMedix Inc | Elizabeth Masson | EVP, Head of Clinical Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Common Stock) | |
CorMedix Inc | Elizabeth Masson | EVP, Head of Clinical Ops | Sale of securities on an exchange or to another person at price $ 6.92 per share. | 21 May 2021 | 8,000 | 0 (0%) | 0% | 6.9 | 55,394 | Common Stock |
CorMedix Inc | Elizabeth Masson | EVP, Head of Clinical Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Common Stock) |